The earnings call highlighted strong order growth, strategic wins, and an optimistic financial outlook, particularly in the Imaging and Nuclear Medicine sectors. However, these positives were tempered by tariff impacts, challenges in the China market, and flat performance in Patient Care Solutions, which affected margins.

Company Guidance -

Q3 2025

In the second quarter of fiscal year 2025, GE HealthCare reported strong financial performance, evidenced by a 2% organic revenue growth, reaching $5 billion, with service revenue increasing by 7% and product revenue by 2%. The company achieved a healthy book-to-bill ratio of 1.07x, exiting the quarter with a record backlog of $21.3 billion, up $2.2 billion year-over-year. Adjusted EBIT margin was reported at 14.6%, despite an 80 basis point year-over-year decline due to tariff impacts. Adjusted EPS grew by 6% to $1.06 per share, aided by a $0.08 tariff impact and a $0.07 benefit from an improved tax rate. Free cash flow for the quarter was $7 million, an increase of $189 million compared to the previous year. The company raised its full-year 2025 organic revenue growth guidance to approximately 3%, with an adjusted EBIT margin forecast between 15.2% and 15.4%, and an anticipated adjusted EPS range of $4.43 to $4.63. GE HealthCare remains focused on mitigating tariff impacts and continues to execute on its D3 strategy, which has been instrumental in securing significant collaborations and expanding its product portfolio.

Strong Order and Revenue Growth

GE HealthCare reported record backlog of $21.3 billion, with organic order growth of 3% year-over-year and first half order growth of 7%. The company secured significant wins including a $250 million 5-year collaboration in Europe.

Strategic Collaborations and Wins

GE HealthCare secured its largest order ever of Omni Legend PET/CT systems and a strategic collaboration with Ascension valued up to $90 million in the first year.

Positive Financial Outlook

The company raised its full-year 2025 organic revenue growth guidance to approximately 3% and adjusted EPS guidance to between $4.43 and $4.63, up from the prior estimate of $3.90 to $4.10.

Advancements in Nuclear Medicine

Orders grew strong double digits across GE HealthCare's diagnostic imaging agents and molecular imaging solutions. The company is well-positioned in the nuclear medicine sector with new product launches and regulatory approvals.

GE Healthcare Technologies Inc (GEHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GEHC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	1.04 / -	1.14	―	―	―
Jul 30, 2025	2025 (Q2)	0.92 / 1.06	1	6.00% (+0.06)
Apr 30, 2025	2025 (Q1)	0.91 / 1.01	0.9	12.22% (+0.11)
Feb 13, 2025	2024 (Q4)	1.26 / 1.45	1.18	22.88% (+0.27)
Oct 30, 2024	2024 (Q3)	1.05 / 1.14	0.99	15.15% (+0.15)
Jul 31, 2024	2024 (Q2)	0.98 / 1.00	0.92	8.70% (+0.08)
Apr 30, 2024	2024 (Q1)	0.91 / 0.90	0.85	5.88% (+0.05)
Feb 06, 2024	2023 (Q4)	1.07 / 1.18	1.31	-9.92% (-0.13)
Oct 31, 2023	2023 (Q3)	0.90 / 0.99	0.88	12.50% (+0.11)
Jul 25, 2023	2023 (Q2)	0.87 / 0.92	1.068	-13.86% (-0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

GEHC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$77.72	$71.64	-7.82%
Apr 30, 2025	$68.06	$70.30	+3.29%
Feb 13, 2025	$85.82	$93.39	+8.82%
Oct 30, 2024	$85.15	$87.08	+2.27%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ge Healthcare Technologies Inc. (GEHC) report earnings?

Ge Healthcare Technologies Inc. (GEHC) is schdueled to report earning on Oct 29, 2025, Before Open (Confirmed).

What is Ge Healthcare Technologies Inc. (GEHC) earnings time?

Ge Healthcare Technologies Inc. (GEHC) earnings time is at Oct 29, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is GEHC EPS forecast?

GEHC EPS forecast for the fiscal quarter 2025 (Q3) is 1.04.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing